stockrowMolina Healthcare, Inc
MOH Healthcare Healthcare Plans
Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024.
- Revenue
- −3.44%
- EPS
- −51.7%
- Free cash flow
- −20.3%
- Total debt
- +2.54%
Quarter to September 2026, against a year earlier
Follow MOH
Alert me
Molina Healthcare, Inc (MOH) EBITDA
Molina Healthcare, Inc's EBITDA for fiscal 2025 was $976.0M, down 48.4% from $1.9B in fiscal 2024. Over the twelve months to 30 September 2026 it was $333.0M. Over the past ten years it has ranged from −$345.0M (fiscal 2017) to $1.9B (fiscal 2024); the current reading is higher than 36% of that period. Molina Healthcare, Inc ranks 8th of 12 Healthcare Plans companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $976.0M | (48.44%) |
| FY2024 | $1.9B | 8.54% |
| FY2023 | $1.7B | 29.28% |
| FY2022 | $1.3B | 17.20% |
| FY2021 | $1.2B | (1.29%) |
| FY2020 | $1.2B | 2.91% |
| FY2019 | $1.1B | (9.94%) |
| FY2018 | $1.3B | — |
| FY2017 | −$345.0M | — |
| FY2016 | $488.0M | (10.13%) |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $144.0M | (22.16%) |
| Jun 2026 | $185.0M | 51.64% |
| Mar 2026 | $122.0M | — |
| Dec 2025 | −$118.0M | — |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| CI Cigna Group compare | $12.7B |
| ELV Elevance Health, Inc. compare | $9.2B |
| HUM Humana Inc. compare | $3.1B |
| CNC Centene Corporation compare | $2.2B |
| OSCR Oscar Health, Inc. compare | $632.0M |
| MOH Molina Healthcare, Inc | $333.0M |
| PGNY Progyny, Inc. compare | $117.9M |
| ALHC Alignment Healthcare, Inc. compare | $76.7M |
| CLOV Clover Health Investments, Corp. compare | $12.7M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on MOH
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement